Viking Therapeutics Inc (NASDAQ:VKTX) shares are falling in Wednesday’s after-hours session after the company reported financial results for the second quarter.Q2 Earnings: Viking Therapeutics reported a second-quarter loss of 58 cents per share, missing analyst estimates for a loss of 46 cents per share, according to Benzinga Pro.The clinical-stage biopharmaceutical company said research and development expenses totaled $60.2 million in the second quarter, up from $23.8 million in the prior year’s quarter. Viking Therapeutics ended the period with $808 ...Full story available on Benzinga.com
Viking Therapeutics Stock Slides After Company Misses Q2 Earnings Estimates
